Vandria

Curated by Signal

Developer of in-vitro screening platform for drug discovery and development

Overview

Developer of in-vitro screening platform for drug discovery and development. The company has created a platform for identifying and discovering small compounds (mitophagy inducers). It aids in the identification of the leading candidate molecule linked to age-related and chronic diseases.

Key facts

Founded: 2018
Headquarters: Lausanne, Switzerland
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Aligned
Provider of Medical Device application life-cycle management (ALM) software solutions
Health TechnologyZurich, Switzerland
OneImpact
Online platform offering community support and medical information for TB patients
Health TechnologyVernier, Switzerland
DeinDoktor
Provider of online platform for appointment booking with orthopedics
Health TechnologyWollerau, Switzerland

About Vandria

What does Vandria do?

Developer of in-vitro screening platform for drug discovery and development.

Where is Vandria headquartered?

Vandria is headquartered in Lausanne, Switzerland.

When was Vandria founded?

Vandria was founded in 2018.

Which sector is Vandria in?

Vandria operates in Health Technology.

Who are Vandria's competitors?

Companies similar to Vandria include Aligned, OneImpact, and DeinDoktor.